GlycoMimetics Inc (GLYC)

0.2824 0.00 (0.00%) USD  |  NASDAQ  |  Jan 07, 15:20
More

GlycoMimetics Cash and Short Term Investments (Annual): 41.79M for Dec. 31, 2023

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 1.074B
Arbutus Biopharma Corp 126.00M
Revance Therapeutics Inc 253.92M
FibroGen Inc 235.59M
Cidara Therapeutics Inc 35.78M